U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399561) titled 'Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy' on Jan. 18.
Brief Summary: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and often persistent adverse effect of oxaliplatin- and paclitaxel-based chemotherapy. While exercise is frequently recommended for patients with CIPN, it remains unclear whether exercise mitigates neuropathic injury itself or primarily improves physical function and quality of life.
This randomized controlled trial evaluates the effects of exercise on CIPN during and after chemotherapy. Patients receiving oxaliplatin for colorectal cancer or paclitaxel for gynecologic cancer are...